Value of the histopathological features in predicting B-RAF status in cutaneous malignant melanoma

被引:0
|
作者
Penaranda, J. M. Suarez [1 ]
Silva, O. Figueroa [1 ]
Gestal, A. Estany [1 ]
Bouso, M. [1 ]
Aliste, C. [1 ]
Aguilar, M. D. Sanchez [1 ]
机构
[1] Clin Hosp, Dept Pathol, Santiago De Compostela, Spain
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
PS-15-012
引用
收藏
页码:S142 / S142
页数:1
相关论文
共 50 条
  • [1] B-RAF Inhibitors: An Evolving Role in the Therapy of Malignant Melanoma
    Shepherd, Cynthia
    Puzanov, Igor
    Sosman, Jeffrey A.
    CURRENT ONCOLOGY REPORTS, 2010, 12 (03) : 146 - 152
  • [2] B-RAF Inhibitors: An Evolving Role in the Therapy of Malignant Melanoma
    Cynthia Shepherd
    Igor Puzanov
    Jeffrey A. Sosman
    Current Oncology Reports, 2010, 12 : 146 - 152
  • [3] The role of B-RAF in melanoma
    Vanessa C. Gray-Schopfer
    Silvy da Rocha Dias
    Richard Marais
    Cancer and Metastasis Reviews, 2005, 24 : 165 - 183
  • [4] The role of B-RAF in melanoma
    Gray-Schopfer, VC
    Dias, SD
    Marais, R
    CANCER AND METASTASIS REVIEWS, 2005, 24 (01) : 165 - 183
  • [5] B-RAF is a therapeutic target in melanoma
    Karasarides, M
    Chiloeches, A
    Hayward, R
    Niculescu-Duvaz, D
    Scanlon, I
    Friedlos, F
    Ogilvie, L
    Hedley, D
    Martin, J
    Marshall, CJ
    Springer, CJ
    Marais, R
    ONCOGENE, 2004, 23 (37) : 6292 - 6298
  • [6] B-RAF: A contributor to the melanoma phenotype
    Heath, E. M. L.
    Kaufman, K. L.
    Christopherson, R. I.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (01): : 29 - 32
  • [7] B-RAF is a therapeutic target in melanoma
    Maria Karasarides
    Antonio Chiloeches
    Robert Hayward
    Dan Niculescu-Duvaz
    Ian Scanlon
    Frank Friedlos
    Lesley Ogilvie
    Douglas Hedley
    Jan Martin
    Christopher J Marshall
    Caroline J Springer
    Richard Marais
    Oncogene, 2004, 23 : 6292 - 6298
  • [8] Erratum, The role of B-RAF in melanoma
    Vanessa C. Gray-Schopfer
    Silvy da Rocha Dias
    Richard Marais
    Cancer and Metastasis Reviews, 2005, 24 : 367 - 367
  • [9] VEMURAFENIB (B-RAF INHIBITOR) ASSOCIATED UVEITIS IN PATIENTS WITH METASTATIC CUTANEOUS MELANOMA
    Sandhu, Sukhpal S.
    Ling, Cecilia
    Lim, Lyndell
    Zamir, Ehud
    Stawell, Richard J.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 118 - 118
  • [10] Mutational status of BRAF and histopathological characteristics in cutaneous malignant melanoma
    Garcia, Alejandro
    Lorente, Constanza
    Elsner, Boris
    Avagnina, Alejandra
    Denninghoff, Valeria
    MEDICINA-BUENOS AIRES, 2019, 79 (04) : 265 - 270